Your browser doesn't support javascript.
loading
Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT.
Nakano, Nobuaki; Utsunomiya, Atae; Matsuo, Keitaro; Yoshida, Noriaki; Seto, Masao; Ohshima, Kouichi; Fujiwara, Hiroshi; Fuji, Shigeo; Takatsuka, Yoshifusa; Ito, Ayumu; Miyamoto, Toshihiro; Suehiro, Youko; Nakamae, Hirohisa; Sawayama, Yasushi; Yuasa, Mitsuhiro; Miyazaki, Yasuhiko; Ota, Shuichi; Imada, Kazunori; Fukuda, Takahiro; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kato, Koji.
Afiliação
  • Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Utsunomiya A; ATL Working Group of Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Matsuo K; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Yoshida N; ATL Working Group of Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Seto M; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Ohshima K; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fujiwara H; Department of Pathology, Kurume University, Kurume, Japan.
  • Fuji S; Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.
  • Takatsuka Y; Department of Pathology, Kurume University, Kurume, Japan.
  • Ito A; Department of Pathology, Kurume University, Kurume, Japan.
  • Miyamoto T; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan.
  • Suehiro Y; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Nakamae H; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Sawayama Y; ATL Working Group of Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Yuasa M; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Miyazaki Y; Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ota S; Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan.
  • Imada K; Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Fukuda T; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Ichinohe T; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
  • Atsuta Y; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Kato K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Blood Adv ; 5(2): 475-486, 2021 01 26.
Article em En | MEDLINE | ID: mdl-33496743
ABSTRACT
Adult T-cell leukemia/lymphoma (ATL) cells frequently exhibit chromosomal abnormalities, including numerical aberrations and structural defects. However, no studies have examined the correlation between these abnormalities and survival in patients with ATL after allogeneic HSCT (allo-HSCT). In this study, 300 patients with ATL (median age, 55 years; range, 24-74) who were registered in a Japanese nationwide registry database were analyzed. The majority (n = 183) had acute ATL. Specimens for chromosomal analysis were collected from bone marrow (n = 166), lymph nodes (n = 86), peripheral blood (n = 41), and other locations (n = 7). In survival analyses, breakpoints at 2q (hazard ratio [HR], 1.63; 95% confidence interval [CI], 1.12-2.38; P = .012) and 5q (HR, 2.18; 95% CI, 1.25-3.80; P = .006) were significantly poor prognostic factors for overall survival (OS). In terms of ATL-related death, loss of chromosome 14 and breakpoints at 3p, 1q, 5q, and 6q were extracted as significantly poor prognostic factors. Moreover, complex karyotypes were associated with ATL-related death. This study of the survival impact of chromosomal abnormalities in patients with ATL after allo-HSCT demonstrated that several structural breakpoints were independent risk factors for OS and ATL-related death.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Transplante de Células-Tronco Hematopoéticas / Linfoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Transplante de Células-Tronco Hematopoéticas / Linfoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão